VEZT VEZT Endometriosis Cell Adhesion Variant

VEZT — The Cellular Glue That Lets Endometrial Cells Take Root Where They Shouldn't

Endometriosis affects an estimated 10% of women of reproductive age, yet on average it
takes 4–11 years from first symptoms to confirmed diagnosis | Diagnosis requires
laparoscopic surgery; symptoms are routinely attributed to normal menstrual pain.
Among the mechanisms proposed to explain why displaced endometrial cells survive and implant
outside the uterus, cell adhesion stands out: ectopic cells must attach to peritoneal surfaces,
evade immune clearance, and establish a blood supply. The VEZT gene encodes one of the
proteins that makes that adhesion possible.

rs4762326 sits within an intron of VEZT (vezatin, adherens junctions transmembrane protein)
on chromosome 12q23.2. It is one of the most consistently replicated common genetic signals
for endometriosis discovered to date, having been identified or confirmed in multiple
independent GWAS cohorts spanning European, East Asian, and admixed populations.

The Mechanism

Vezatin is a ubiquitous transmembrane component of adherens junctions — the molecular
structures that anchor epithelial cells to one another and to the extracellular matrix.
It forms part of the cadherin–catenin complex at cell-cell contact sites, linking actin
cytoskeleton dynamics to epithelial stability and cell migration. In ectopic endometrial
tissue, dysregulated adherens junction activity may lower the energy barrier for implantation
on non-uterine surfaces such as the peritoneum, ovaries, and bowel serosa.

The rs4762326 T allele is intronic, so it does not change the vezatin amino acid sequence
directly. Instead, it likely alters VEZT transcription or splicing in endometrial stromal
and epithelial cells — potentially up-regulating cell adhesion capacity during the retrograde
menstruation cycle phase when endometrial fragments are shed into the peritoneal cavity.
Functional studies characterizing the exact regulatory effect of this intronic variant are
ongoing; the biological plausibility of VEZT as an endometriosis susceptibility gene is
supported by the consistent genetic association and the central role adherens junctions
play in ectopic implantation.

The Evidence

The clearest quantification of this variant's effect comes from a
meta-analysis of 17,045 endometriosis cases and 191,596 controls across eleven GWAS
datasets | Sapkota et al. Nature Communications, 2017.
The T allele at rs4762326 reached genome-wide significance for endometriosis overall
(OR 1.08, 95% CI 1.05–1.11, p = 2 × 10⁻⁹) and was nominally significant in the
European-ancestry subset (OR 1.07, p = 1 × 10⁻⁶). The T allele frequency was 0.47
in this dataset. In the Japanese-ancestry arm of the same study, the rare G allele
at this multiallelic position showed an OR of 1.22, though the G allele is essentially
absent in non-Asian populations (frequency < 0.001 in gnomAD global data).

The locus was independently prioritized at substantially higher significance
(p = 4 × 10⁻¹⁴) in a 2023 GWAS of shared genetic architecture across gynaecological
disorders | Kiewa et al. Neuroendocrinology, 2023,
confirming rs4762326 as the top locus in analyses jointly modelling endometriosis,
uterine fibroids, ovarian cysts, menorrhagia, and menopausal symptoms.

The 2023 Nature Genetics meta-analysis by Rahmioglu and colleagues,
the largest endometriosis GWAS to date, further established the genetic comorbidity
of endometriosis with chronic pain and inflammatory conditions, a context consistent
with VEZT's role in the inflammatory peritoneal microenvironment surrounding ectopic implants.

An OR of 1.08 per allele is modest in absolute terms but robust across diverse cohorts.
The consistent replication across European and East Asian populations — despite very
different T allele frequencies — strengthens the biological interpretation: this is
not a population-specific variant but a genuine pleiotropic signal in the biology
of ectopic endometrial cell implantation.

Practical Implications

The T allele at rs4762326 raises the population probability of endometriosis modestly.
For individual risk counselling, the primary value of this result is raising awareness of
endometriosis symptoms and supporting a lower threshold for timely investigation —
rather than serving as a diagnostic marker in isolation.

Women with this variant who experience hallmark symptoms — dysmenorrhea disrupting daily
function, deep dyspareunia, cyclic pelvic or bowel pain, or unexplained sub-fertility —
should escalate to specialist evaluation rather than accept symptom normalization. The
typical diagnostic gap of nearly a decade is driven by clinicians and patients both
underestimating pain severity; genetic awareness can help counteract that bias.

Interactions

rs12700667 (7p15.2 locus, near HOXA10/HOXA11): The 7p15.2 locus is one of the
most strongly replicated endometriosis susceptibility signals, with an OR of 1.20 for
any endometriosis and 1.38 for moderate-to-severe disease. Both loci contribute to
endometriosis risk through different biological pathways — rs12700667 likely through
HOX gene-mediated endometrial programming, rs4762326 through cell adhesion capacity.
Women carrying risk alleles at both loci may have additive susceptibility, though no
formal gene-gene interaction paper has been published for this pair.

rs7521902 (WNT4 locus): WNT4 is one of the most significantly associated
endometriosis loci (OR up to 1.21) and also implicates cell signalling in endometrial
tissue specification. The combination of a cell adhesion variant (VEZT, rs4762326) and
a cell signalling variant (WNT4, rs7521902) in the same individual would represent
two mechanistically distinct contributions to ectopic implantation risk.

rs1250248 (FN1 — fibronectin 1): FN1 encodes fibronectin, a major extracellular
matrix glycoprotein that interacts directly with cell surface adhesion receptors.
An epistatic interaction between the FN1 locus and WNT4 has been described for ovarian
endometriosis. Fibronectin and vezatin operate in adjacent layers of the adhesion
machinery; carrying variants in both genes could further amplify ectopic implantation
efficiency.

For a supervisor compound action proposal: women carrying both the rs4762326 T allele
(VEZT cell adhesion) and the rs12700667 A allele (7p15.2/HOX regulation) represent
a plausible high-risk subgroup for endometriosis monitoring. Combined recommendation:
lower threshold for specialist gynecological evaluation at first symptom onset, and
proactive baseline AMH and antral follicle count by age 28. Evidence level: moderate
(both loci established; combined effect is additive assumption, not formally tested).